Ignite Creation Date:
2024-05-06 @ 7:19 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05974410
Status:
AVAILABLE
Last Update Posted:
2023-08-03
First Post:
2023-07-26
Brief Title:
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients
Sponsor:
AVM Biotechnology Inc
Organization:
AVM Biotechnology Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Tumor Brain |
| Glioblastoma |
| Squamous Cell Carcinoma |
| Hodgkin Lymphoma |
| Non-hodgkin Lymphoma |
| Breast Cancer |
| Prostate Cancer |
| Gastric Cancer |
| Ovarian Cancer |
| Acute Leukemia |
| Pancreatic Cancer |
| Spindle Cell Sarcoma |
| Cancer |
| Tumor Solid |
Keywords: